Adaptive strategies of the candidate probiotic E. coli Nissle in the mammalian gut

Probiotics are living microorganisms that are increasingly used as gastrointestinal therapeutics by virtue of their innate or engineered genetic function. Unlike abiotic therapeutics, probiotics can replicate in their intended site, subjecting their genomes and therapeutic properties to natural selection. We exposed the candidate probiotic E. coli Nissle (EcN) to the mouse gastrointestinal tract over several weeks, systematically altering the diet and background microbiota complexity. In-transit EcN accumulates genetic mutations that modulate carbohydrate utilization, stress response, and adhesion to gain competitive fitness, while previous exposure to antibiotics reveals an acquisition of resistance. We then leveraged these insights to generate an EcN strain that shows therapeutic efficacy in a mouse model of phenylketonuria and found that it was genetically stable over 1 week, thereby validating EcN's utility as a chassis for engineering. Collectively, we demonstrate a generalizable pipeline that can be applied to other probiotics to better understand their safety and engineering potential.

[1]  L. Hoskins,et al.  Mucin degradation in human colon ecosystems. Isolation and properties of fecal strains that degrade ABH blood group antigens and oligosaccharides from mucin glycoproteins. , 1985, The Journal of clinical investigation.

[2]  Andrew J. Page,et al.  Roary: rapid large-scale prokaryote pan genome analysis , 2015, bioRxiv.

[3]  F. Taddei,et al.  Mutations in two global regulators lower individual mortality in Escherichia coli , 2007, Molecular microbiology.

[4]  B. Priem,et al.  Chaperone-assisted expression of KfiC glucuronyltransferase from Escherichia coli K5 leads to heparosan production in Escherichia coli BL21 in absence of the stabilisator KfiB , 2016, Applied Microbiology and Biotechnology.

[5]  E. Rubin,et al.  Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.

[6]  Haixu Tang,et al.  Rate and molecular spectrum of spontaneous mutations in the bacterium Escherichia coli as determined by whole-genome sequencing , 2012, Proceedings of the National Academy of Sciences.

[7]  Paul S. Cohen,et al.  Comparison of Carbon Nutrition for Pathogenic and Commensal Escherichia coli Strains in the Mouse Intestine , 2008, Infection and Immunity.

[8]  J. Keasling,et al.  The Need for Integrated Approaches in Metabolic Engineering. , 2016, Cold Spring Harbor perspectives in biology.

[9]  Jonathan Sidi,et al.  heatmaply: an R package for creating interactive cluster heatmaps for online publishing , 2017, Bioinform..

[10]  Otto X. Cordero,et al.  Ecology drives a global network of gene exchange connecting the human microbiome , 2011, Nature.

[11]  Paolo Visca,et al.  Functional Characterization and Regulation of gadX, a Gene Encoding an AraC/XylS-Like Transcriptional Activator of the Escherichia coli Glutamic Acid Decarboxylase System , 2002, Journal of bacteriology.

[12]  H. Steingrimsdottir,et al.  Mutant sequences in the rpsL gene of Escherichia coli B/r: Mechanistic implications for spontaneous and ultraviolet light mutagenesis , 1992, Molecular and General Genetics MGG.

[13]  Rob Knight,et al.  Identifying genetic determinants needed to establish a human gut symbiont in its habitat. , 2009, Cell host & microbe.

[14]  T. R. Licht,et al.  Estimation of Growth Rates of Escherichia coli BJ4 in Streptomycin-Treated and Previously Germfree Mice by In Situ rRNA Hybridization , 1999, Clinical Diagnostic Laboratory Immunology.

[15]  Nathan Crook,et al.  Multiscale Evolutionary Dynamics of Host-Associated Microbiomes , 2018, Cell.

[16]  J. Faith,et al.  Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice , 2011, Proceedings of the National Academy of Sciences.

[17]  David S. Wishart,et al.  PHASTER: a better, faster version of the PHAST phage search tool , 2016, Nucleic Acids Res..

[18]  I. Hunt von Herbing,et al.  Genetically engineered probiotic for the treatment of phenylketonuria (PKU); assessment of a novel treatment in vitro and in the PAHenu2 mouse model of PKU , 2017, PloS one.

[19]  U. Sonnenborn,et al.  The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic , 2009 .

[20]  James J Collins,et al.  “Deadman” and “Passcode” microbial kill switches for bacterial containment , 2015, Nature chemical biology.

[21]  Tami D. Lieberman,et al.  Inexpensive Multiplexed Library Preparation for Megabase-Sized Genomes , 2015, bioRxiv.

[22]  Matthew Fraser,et al.  InterProScan 5: genome-scale protein function classification , 2014, Bioinform..

[23]  D. Laux,et al.  Escherichia coli F-18 and E. coli K-12 eda mutants do not colonize the streptomycin-treated mouse large intestine , 1996, Infection and immunity.

[24]  Molly K. Gibson,et al.  Gut resistome development in healthy twin pairs in the first year of life , 2015, Microbiome.

[25]  N. Majdalani,et al.  The RpoS-mediated general stress response in Escherichia coli. , 2011, Annual review of microbiology.

[26]  Fuzhong Zhang,et al.  Negative feedback regulation of fatty acid production based on a malonyl-CoA sensor-actuator. , 2015, ACS synthetic biology.

[27]  G. Dantas,et al.  The Shared Antibiotic Resistome of Soil Bacteria and Human Pathogens , 2012, Science.

[28]  Jinling Huang,et al.  Horizontal gene transfer: building the web of life , 2015, Nature Reviews Genetics.

[29]  Roy Kishony,et al.  Genetic variation of a bacterial pathogen within individuals with cystic fibrosis provides a record of selective pressures , 2013, Nature Genetics.

[30]  Itai Sharon,et al.  Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMT , 2018, Cell.

[31]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[32]  W. S. Denney,et al.  An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans , 2019, Science Translational Medicine.

[33]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[34]  V. Young,et al.  Faecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection: current promise and future needs , 2013, Current opinion in gastroenterology.

[35]  Torsten Seemann,et al.  Prokka: rapid prokaryotic genome annotation , 2014, Bioinform..

[36]  K. Hantke,et al.  The colicin G, H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN. , 2003, Microbiology.

[37]  A. Krivoruchko,et al.  Industrial systems biology and its impact on synthetic biology of yeast cell factories. , 2016, Biotechnology and bioengineering.

[38]  Vanni Bucci,et al.  Engineered Probiotic for the Inhibition of Salmonella via Tetrathionate-Induced Production of Microcin H47. , 2018, ACS infectious diseases.

[39]  William A. Walters,et al.  Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms , 2012, The ISME Journal.

[40]  Jeffrey E. Barrick,et al.  Identification of mutations in laboratory-evolved microbes from next-generation sequencing data using breseq. , 2014, Methods in molecular biology.

[41]  Sergey I. Nikolenko,et al.  SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing , 2012, J. Comput. Biol..

[42]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[43]  S. Gottesman,et al.  The Novel Transcription Factor SgrR Coordinates the Response to Glucose-Phosphate Stress , 2007, Journal of bacteriology.

[44]  Martin C. Frith,et al.  Improved search heuristics find 20 000 new alignments between human and mouse genomes , 2014, Nucleic acids research.

[45]  L. Tailford,et al.  Mucin glycan foraging in the human gut microbiome , 2015, Front. Genet..

[46]  Sergei L. Kosakovsky Pond,et al.  Datamonkey 2010: a suite of phylogenetic analysis tools for evolutionary biology , 2010, Bioinform..

[47]  Tami D. Lieberman,et al.  Adaptive evolution within the gut microbiome of individual people , 2017, bioRxiv.

[48]  Heng Li,et al.  A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data , 2011, Bioinform..

[49]  S. Adhya,et al.  The galactose regulon of Escherichia coli , 1993, Molecular microbiology.

[50]  F. Gunzer,et al.  Intestinal immunity of Escherichia coli NISSLE 1917: a safe carrier for therapeutic molecules. , 2005, FEMS immunology and medical microbiology.

[51]  A. Benítez-Páez,et al.  Regulation of expression and catalytic activity of Escherichia coli RsmG methyltransferase. , 2012, RNA.

[52]  G. Gottschalk,et al.  Analysis of the Genome Structure of the Nonpathogenic Probiotic Escherichia coli Strain Nissle 1917 , 2004, Journal of bacteriology.

[53]  H. Bujard,et al.  Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements. , 1997, Nucleic acids research.

[54]  A. Kurilshikov,et al.  Environment dominates over host genetics in shaping human gut microbiota , 2018, Nature.

[55]  Itai Sharon,et al.  Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features , 2018, Cell.

[56]  K. Hayes,et al.  The K5 Capsule of Escherichia coli Strain Nissle 1917 Is Important in Stimulating Expression of Toll-Like Receptor 5, CD14, MyD88, and TRIF Together with the Induction of Interleukin-8 Expression via the Mitogen-Activated Protein Kinase Pathway in Epithelial Cells , 2010, Infection and Immunity.

[57]  T. Conway,et al.  Molecular genetic characterization of the Escherichia coli gntT gene of GntI, the main system for gluconate metabolism , 1997, Journal of bacteriology.

[58]  William E Bentley,et al.  Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models , 2017, Nature Communications.

[59]  D. Nielsen,et al.  Styrene biosynthesis from glucose by engineered E. coli. , 2011, Metabolic engineering.

[60]  Thomas L. Madden,et al.  Domain enhanced lookup time accelerated BLAST , 2012, Biology Direct.

[61]  T. Dandekar,et al.  Complete genome sequence of the gram-negative probiotic Escherichia coli strain Nissle 1917. , 2014, Journal of biotechnology.

[62]  T. Zisman,et al.  The microbiota in inflammatory bowel disease: current and therapeutic insights , 2017, Journal of inflammation research.

[63]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration , 2012, Briefings Bioinform..

[64]  Peer Bork,et al.  Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees , 2016, Nucleic Acids Res..

[65]  A. Gasbarrini,et al.  Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update. , 2016, World journal of gastroenterology.

[66]  Christopher A. Miller,et al.  VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. , 2012, Genome research.

[67]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[68]  G. Dantas,et al.  Functional Metagenomics to Study Antibiotic Resistance. , 2017, Methods in molecular biology.

[69]  Katy C. Kao,et al.  Evolved Osmotolerant Escherichia coli Mutants Frequently Exhibit Defective N-Acetylglucosamine Catabolism and Point Mutations in Cell Shape-Regulating Protein MreB , 2014, Applied and Environmental Microbiology.

[70]  Glenn R. Gibson,et al.  The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic , 2014 .

[71]  D. Goodlett,et al.  Human symbionts inject and neutralize antibacterial toxins to persist in the gut , 2016, Proceedings of the National Academy of Sciences.

[72]  R. Stevens,et al.  Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuria , 2008, Proceedings of the National Academy of Sciences.

[73]  Alexandros Stamatakis,et al.  RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies , 2014, Bioinform..

[74]  Eric Talevich,et al.  CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing , 2016, PLoS Comput. Biol..

[75]  M. Schembri,et al.  The Escherichia coli K-12 gntP gene allows E. coli F-18 to occupy a distinct nutritional niche in the streptomycin-treated mouse large intestine , 1996, Infection and immunity.

[76]  T. Conway,et al.  Commensal and Pathogenic Escherichia coli Metabolism in the Gut , 2015, Microbiology spectrum.

[77]  Zhengwei Zhu,et al.  CD-HIT: accelerated for clustering the next-generation sequencing data , 2012, Bioinform..

[78]  Robert C. Edgar,et al.  BIOINFORMATICS APPLICATIONS NOTE , 2001 .

[79]  Joe E Grissom,et al.  Carbon nutrition of Escherichia coli in the mouse intestine. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[80]  Susanne Hempel,et al.  Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. , 2012, JAMA.

[81]  Adam B Fisher,et al.  Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria , 2018, Nature Biotechnology.